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How commensal microbiota contributes to immune
cell homeostasis at barrier surfaces is poorly under-
stood. Lamina propria (LP) T helper 17 (Th17) cells
participate in mucosal protection and are induced
by commensal segmented filamentous bacteria
(SFB). Here we show that MHCII-dependent antigen
presentation of SFB antigens by intestinal dendritic
cells (DCs) is crucial for Th17 cell induction. Expres-
sionofMHCII onCD11c+ cellswasnecessary andsuf-
ficient for SFB-induced Th17 cell differentiation.Most
SFB-induced Th17 cells recognized SFB in anMHCII-
dependent manner. SFB primed and induced Th17
cells locally in the LPandTh17cell inductionoccurred
normally in mice lacking secondary lymphoid organs.
The importance of other innate cells was unveiled by
the finding that MHCII deficiency in group 3 innate
lymphoid cells (ILCs) resulted in an increase in SFB-
independent Th17 cell differentiation. Our results
outline the complex role of DCs and ILCs in the regu-
lation of intestinal Th17 cell homeostasis.
INTRODUCTION
Commensal bacteria control mucosal and systemic immune
responses (Macpherson and Harris, 2004). It is increasingly
becoming appreciated that the composition of gut microbiota
affects the homeostasis or function of most immune subsets in
the intestinal lamina propria (LP), as well as systemically (Hill
and Artis, 2010; Hooper et al., 2012). In particular, the homeosta-
sis of steady-statemucosal T cell subsets is controlled by signals
from various components of the microbiota (Honda and Littman,
2012; Ivanov and Honda, 2012). T helper 17 (Th17) and regula-
tory T (Treg) cells are the most abundant lamina propria CD4
T cell subsets at steady state. Treg cells are crucial for establish-
ment of oral tolerance and for curbing excessive inflammatory
responses toward the large numbers of resident commensal594 Immunity 40, 594–607, April 17, 2014 ª2014 Elsevier Inc.bacteria (Josefowicz et al., 2012; Nutsch and Hsieh, 2012).
Th17 cells are characterized by the production of the cytokine
interleukin-17 (IL-17) but might also produce a number of other
effector cytokines, e.g., IL-17F and IL-22. Th17 cell cytokines
function as important activators of innate immune mechanisms,
such as recruitment of neutrophils and induction of antimicrobial
peptide production from epithelial cells, and Th17 cells play key
roles in mucosal defense against bacteria and fungi (Korn et al.,
2009). In general, Treg cells and Th17 cells have antagonistic
functions and the balance between these two subsets is an
important determinant of how the mucosal immune system will
respond to external challenges (Honda and Littman, 2012).
Treg and Th17 cell differentiation is controlled by the expres-
sion of the lineage-specific transcription factors forkhead
box P3 (Foxp3) and RAR-related orphan receptor gt (RORgt),
respectively, which are differentially induced during T cell activa-
tion by a specific combination of T cell receptor (TCR) and cyto-
kine signals (Josefowicz et al., 2012; Korn et al., 2009). Cytokines
responsible for the differentiation of Th17 cells have been well
defined in vitro (Korn et al., 2009). In contrast, the role of individ-
ual cytokines in controlling Th17 cell numbers or fine-tuning Th17
cell differentiation in vivo is not clearly understood, and the role
and nature of the TCR signals, including the context of antigen
presentation, the participating antigens, the strength and loca-
tion of antigen priming, and the receptor specificities of natu-
rally-occurring Th17 cells, are unknown.
At steady state, both Th17 and Treg cells are enriched in the
intestinal LP. This is most likely due to their unique roles in
mucosal protection and the immune requirements of the gut
microenvironment. Treg and Th17 cell numbers in the gut
are controlled by signals from different components of the
commensal microbiota. Colonic Treg cells are induced by a
combination of group IV and XIVa Clostridia, and small intestinal
(SI) Th17 cells are induced by segmented filamentous bacteria
(SFB) (Atarashi et al., 2013; Atarashi et al., 2011; Gaboriau-Rou-
thiau et al., 2009; Ivanov et al., 2009). Indeed, the increase in the
Treg:Th17 cell ratio in the colon versus small intestine closely re-
flects the increase in relative abundance of group IV and XIVa
Clostridia and decrease in SFB epithelial colonization between
these two locations. Although both Treg and Th17 cells can
be generated in the absence of the inducing bacteria, these
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set, which profoundly influences intestinal immune responses
(Atarashi et al., 2011; Ivanov et al., 2009). Moreover, in both
cases, systemic effects on Th17 or Treg responses have also
been demonstrated (Atarashi et al., 2011; Berer et al., 2011;
Lee et al., 2011; Wu et al., 2010).
How Clostridia and SFB respectively modulate Treg and Th17
cell homeostasis is currently unknown. Both groups of commen-
sals reside in the lumen and do not normally cross the epithelial
barrier. It is generally thought that commensal-derived metabo-
lites gain access to the LP and act on LP immune cells to
generate a cytokine environment that promotes Treg or Th17
cell differentiation. In support of such mechanism, commensal-
derived short-chain fatty acids induce epigenetic changes
to stabilize the Treg cell differentiation program (Arpaia et al.,
2013; Furusawa et al., 2013; Smith et al., 2013). In the case of
SFB-induced Th17 cell differentiation, Th17 cell-inducing micro-
biota modifies LP dendritic cell (DC) cytokine production and
SFB induce secretion of cytokines, such as serum amyloid A,
from intestinal epithelial cells (IECs) that might affect DC cytokine
production (Ivanov et al., 2009). However, whether these SFB-
induced changes in the cytokine environment are sufficient for
Th17 cell induction is not known.
Here we focused on characterizing the mechanisms by which
SFB induce Th17 cells in the SI LP, the innate immune cells
involved, and the geography of Th17 cell induction. We find
that although SFB-induced cytokine environment is important,
it is not sufficient to promote Th17 cell differentiation of activated
CD4 T cells. We show that, in vivo, SFB-mediated Th17 cell in-
duction in the gut involves SFB-derived antigens and generation
of SFB-specific Th17 cells. SFB-induced Th17 cells, but not in-
testinal Th17 cells in general, required antigen presentation by
MHCII in the periphery. In contrast, SFB-independent Th17 cells
could be generated even in the absence of MHCII. We also show
that most, if not all, SFB-induced intestinal Th17 cells recognize
SFB antigens, in contrast to non-Th17 CD4 T cells and to the
small number of Th17 cells present in SFB-negative animals.
DC restricted expression of MHCII was necessary and sufficient
for induction of Th17 cells by SFB, demonstrating that CD11c+
intestinal DCs (iDCs) are the cells that acquire and present SFB
antigens for Th17 cell induction. At the same time, ablation of
MHCII-expression in group 3 RORgt+ innate lymphoid cells
(ILC3) did not preclude induction of Th17 cells by SFB, but led
to an increase in SFB-independent Th17 cell numbers in the
gut, demonstrating that ILCs curb Th17 cell differentiation in
the absence of SFB in an MHCII-dependent manner. Further-
more, priming of microbiota-induced Th17 cells was detected
only in the gut mucosa and Th17 cell induction was unaffected
in mice lacking peripheral lymph nodes (LN) and organized
gut-associated lymphoid tissues (GALT), suggesting that anti-
gen presentation, T cell priming, and Th17 cell differentiation
occur locally in the LP.
RESULTS
Microbiota-Induced Intestinal Th17 Cells Are Selected
on MHCII
SFB preferentially increase Th17 cell proportions in the SI LP
(Ivanov et al., 2009; see Figure S1A available online). To examinethe dependence of intestinal microbiota-induced Th17 cells
on MHCII, we analyzed intestinal CD4 T cell homeostasis in
MHCII-deficient mice (H2-Ab1/). H2-Ab1/ animals have
greatly decreased numbers of CD4 T cells due to lack of selec-
tion onMHCII. However, a small subset of CD4 T cells is still pre-
sent in spleen and lymph nodes (Cosgrove et al., 1991; Grusby
et al., 1991). The small and large intestinal lamina propria of
H2-Ab1/ animals contained a substantial CD4 T cells popula-
tion (Figure 1A). The CD4 T cell population in H2-Ab1/ animals
contained an expanded proportion of Foxp3+ Treg cells in all tis-
sues examined (Figure 1A; Figure S1B). In contrast, SI LP Th17
cells were decreased in SFB-positive H2-Ab1/ animals
compared to wild-type (WT) controls (Figure 1A). To examine
whether Th17 cells in H2-Ab1/ mice are controlled by SFB,
we compared T cell subsets in the presence and absence of
SFB. Th17 cell numbers varied greatly in H2-Ab1/ mice (Fig-
ure 1B). However, in contrast to WT mice, SFB-positive
H2-Ab1/ mice did not have significantly increased Th17 cell
percentages in the gut (Figure 1B). Therefore, even though Th17
cells can be generated in the absence of MHCII, SFB do not
induce further Th17 cell differentiation inMHCII-deficient animals.
H2-Ab1/mice possess diverse, but quite distinct CD4 T cell
repertoire (Cardell et al., 1995). In order to examine whether
MHCII expression is required for SFB-mediated induction of
WT Th17 cells, we performed adoptive transfer experiments.
We first established that adoptively transferred WT CD4 T cells
develop into Th17 cells in the SI LP in an SFB-dependent
manner. Indeed, donor WT CD4 T cells were easily detected in
the SI LP of SFB-negative and SFB-positive recipients, but ac-
quired IL-17 expression only in SFB-positive recipients, similarly
to endogenous CD4 T cells (Figures 1C and 1D). Purified naive
CD4 T cells also generated Th17 cells only in the SI LP of SFB-
positive hosts (Figures S1C and S1D). We next transferred WT
CD4 T cells into SFB-positive WT and H2-Ab1/ recipients.
WT CD4 T cells were detected in large numbers in the SI LP of
H2-Ab1/ recipients but did not generate any Th17 cells even
in the presence of SFB (Figures 1E and 1F). Identical results
were obtained after transfer of purified naive CD4 T cells (Figures
S1C and S1D). Collectively, these data demonstrate that the in-
duction of LP Th17 cells by SFB requiresMHCII expression in the
periphery.
SFB-Induced Intestinal Th17 Cells Recognize SFB
Antigens
SFB presence does not promote Th17 cell differentiation in
MHCII-deficient CD4 T cells, suggesting that SFB provide
more than just specific cytokine environment. We, therefore,
examined SFB effects on Th17 cell induction in two TCR Tg
models – OTII and TRP-1, which recognize peptides from
chicken ovalbumin (OVA) and mouse tyrosinase related protein
1 (TRP-1) respectively (Muranski et al., 2008). We first examined
OTII mice on a RAG-sufficient background. These mice con-
tained large number of CD4 T cells in the LP and a high propor-
tion of these cells expressed IL-17 in SFB-positive mice, and
even in the absence of OVA (Figure S2A). In contrast to spleen
and MLNs, CD4 T cells in the gut contained a large fraction
of non-Tg TCRs as demonstrated by the low proportion of
Va2hiVb5hi Tg CD4 T cells (Figure S2B). We therefore used this
selection against transgenic TCRs in the LP to compare theImmunity 40, 594–607, April 17, 2014 ª2014 Elsevier Inc. 595
Figure 1. Induction of Intestinal Th17 Cells by SFB Requires MHCII Expression in the Periphery
(A) Th17 and Treg cell proportions in SI LP of SFB-positiveWT andMHCII-deficient (H2-Ab1/) mice. Foxp3 and cytokine staining plots are gated on TCRb+CD4+
cells.
(B) Th17 and Treg cell proportions in SI LP of SFB-negative (Jacksonmicrobiota) and SFB-positive (Taconic microbiota) WT andH2-Ab1/mice. Plots gated on
TCRb+CD4+ cells.
(C and D) WT CD45.1+ CD4 T cells were adoptively transferred into WT CD45.2 mice before or 12 days after SFB colonization. Cytokine expression in host
(CD45.2+) and donor (CD45.1+) SI LP TCRb+CD4+ cells 2 weeks after transfer. Data from one of multiple experiments are shown.
(E and F) Th17 cell induction inWT CD4 T cells 2 weeks after transfer into SFB-positive WT andMHCII-deficient recipients. Plots gated on TCRb+CD4+ cells. Data
from one of multiple experiments are shown. Error bars represent SD of the mean.
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cells expressing alternative TCRs. As shown on Figure S2A,
Va2hiVb5hi Tg CD4 T cells expressed very little IL-17, compared
to the remaining CD4 T cells, even after activation with the
cognate antigen (OVA). In agreement with this result, virtually
all IL-17 expressing cells in the LP, expressed alternative
TCRs, demonstrated an exclusion of Tg TCRs at the expense
of endogenously formed TCRs with broad antigenic specificities
in the Th17 cell subset (Figure S2C). As a result, purified intestinal
IL-17+ CD4 T cells from OTII.B6 Tg mice responded equally well
to OVA and to SFB antigens, in sharp contrast to lymph node
CD4 T cells, which responded to OVA only (Figure S2D). These
results demonstrate that the intestinal Th17 cell population in
OTII.B6 Tgmice is enriched for non-Tg specificities, due to favor-
able coexpression of nontransgenic TCRs. They also suggest
that non-SFB Tg T cells, e.g., OTII cells, are not efficiently
induced into the Th17 cell lineage by SFB.
To more directly examine the effects of SFB on non-SFB Tg
T cells, we examined TCR Tg animals on a RAG-deficient596 Immunity 40, 594–607, April 17, 2014 ª2014 Elsevier Inc.background, which lack alternative endogenous TCRs. In both,
OTII.RAG and TRP-1.RAG Tg mice small numbers of Tg T cells
were present in the SI LP in the absence of the cognate antigen,
but none of these cells expressed IL-17 even after SFB coloni-
zation (Figure 2A; Figures S2E and S2F). LP Tg T cells were
activated and expanded following administration of cognate an-
tigen, which also led to induction of effector Th1 and Th17 cells
(Figure 2A; Figures S2E and S2F). However, even in the presence
of the cognate antigen, SFB colonization did not induce further
conversion of Tg T cells into Th17 cells (Figure 2A). Moreover,
SFB colonization did not induce Th17 cell differentiation of
TRP-1.RAG Tg CD4 T cells transferred into WT mice separately
or together withWTCD4 T cells, despite considerable expansion
and activation of the Tg T cells and despite the presence of
endogenous SFB-induced Th17 cells and induction of Th17
cell differentiation in cotransferred WT cells (Figures S3A and
S3B). Combined, these experiments demonstrate that SFB-
conditioned intestinal environment is not sufficient to induce
IL-17 expression in all activated CD4 T cells.
Figure 2. SFB-Induced Intestinal Th17 Cells Preferentially Respond to SFB Antigens
(A) Th17 cell proportions in the SI LP of OTII.RAG and TRP-1.RAG TCR Tgmice before and after SFB colonization in the absence or presence of cognate antigen.
Representative data from five independent experiments are shown.
(B and C) Proliferation response of sorted SI LP TCRb+CD4+ cells from SFB-negative (Jax) and SFB-positive (Tac) WT B6mice to SFB (B and C) or other bacterial
antigens (C). T cell proliferation was scored by dye dilution on day 3. Ec, E. coli, Cp,Clostridium perfringens; MIB, mouse intestinal bacteria (cultured isolates from
feces of SFB-negative (Jackson) mice); ‘‘–’’ means no antigen. Representative data from five independent experiments are shown.
(D) SI LP TCRb+CD4+ cells were purified from SFB-negative (No SFB) and SFB-positive (SFB+) WT mice and cocultured with SFB antigens as in (B) and WT or
H2-Ab1/ DCs. Data from two independent experiments are shown.
(E and F) SI LP GFP+ (Th17) and GFP (non-Th17) TCRb+CD4+ cells from SFB-positive Il17GFPmice were stimulated in vitro with SFB (E and F) or various bacterial
antigens (F) as in (B) or with lysates from germ-free (GF) or SFB-negative SPF (SPF) animals. Representative data from multiple experiments are shown.
(G) SI LP GFP+ (Th17) and GFP (non-Th17) TCRb+CD4+ cells from SFB-positive (SFB+) or SFB-negative (No SFB) Il17GFP mice were stimulated in vitro with SFB
antigens as in (B). Representative data from two independent experiments are shown. Error bars represent SD of the mean.
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tially respond to SFB. We isolated CD4 T cells from SI LP of
SFB-positive and SFB-negative WT mice and compared their
response to SFB antigens ex vivo. Purified SI LP CD4 T cells
fromSFB-positiveWTmice responded toSFBantigens,whereas
SI LP CD4 T cells isolated from SFB-negative mice did not (Fig-
ure 2B). In contrast, SI LP CD4 T cells from SFB-positive and
SFB-negative mice did not respond significantly to a number of
non-SFB bacteria, including Gram-negative E. coli, Gram-posi-
tive Clostridium perfringens, and cultured murine intestinal
isolates (Figure 2C), demonstrating that LP CD4 T cells fromSFB-positive animals are specifically enriched for SFB reactiv-
ities. The SFB-specific response required antigen presenting
cells and MHCII expression, because purified WT SI LP CD4
T cells from SFB-positive mice did not respond to SFB antigens
in the absence of DCs or when cocultured with MHCII-deficient
DCs as antigen-presenting cells (Figure 2D; data not shown).
To investigate directly the response of gut Th17 cells, we pu-
rified GFP+ (Th17) and GFP (non-Th17) CD4 T cells from the
SI LP of SFB-colonized Il17GFP reporter mice (Figure S3C) and
stimulated them in vitro with various bacterial lysates. Th17
cells responded strongly to SFB, whereas non-Th17 cells didImmunity 40, 594–607, April 17, 2014 ª2014 Elsevier Inc. 597
Figure 3. Most Intestinal SFB-Induced Th17 Cells Recognize SFB
T cell hybridomas were generated from SI LP GFP+ (Th17) and GFP (non-Th17) CD4 T cells from SFB-positive Il17GFP mice. Data combined from two inde-
pendent experiments are shown.
(A) Number of hybridomas responding to SFB.
(B) Response of individual hybridomas (percentage of maximum anti-CD3 and anti-CD28 stimulation) to SFB or E. coli antigens as assessed by IL-2 production.
Clones were ordered in decreasing amounts of IL-2 production.
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response of purified Th17 cells was specific to SFB, because the
same cells did not respond significantly to cultured bacteria (Fig-
ure 2F). In response to SFB, all proliferated GFP+ cells continued
to express IL-17 (GFP) (Figure S3G), in contrast to the small pro-
portion of proliferated GFP cells, which remainedmostly IL-17
(Figure S3G). Furthermore, LP Th17 cells did not respond to
lysates prepared from feces of germ-free (GF) or SFB-negative
conventionally raised mice (SPF) that contained similar numbers
of total bacteria (Figure 2F), confirming that the response is SFB-
specific. To examine whether the response is directed toward an
antigen from SFB, as opposed to an SFB-induced host protein,
we prepared lysates from SFB filaments purified by cell sorting
(Figure S3D). LP Th17 cells responded to sorted SFB filaments,
whereas non-Th17 cells did not (Figure S3E). We conclude
that LP Th17 cells respond to SFB-derived protein antigens. To
examine whether the SFB-specific response in intestinal Th17
cells is directed by the presence of SFB, we purified GFP+
(Th17) cells from SI LP of Il17GFP reporter mice before and
after SFB colonization and examined their response to SFB. In
contrast to Th17 cells isolated from SFB-positive mice, Th17
cells from SFB-negative mice did not proliferate in response to598 Immunity 40, 594–607, April 17, 2014 ª2014 Elsevier Inc.the same SFB antigen preparation (Figure 2G). Similar results
were obtained when Th17 cells were isolated on the basis of
RORgt expression fromSFB-positive and SFB-negativeRorcGFP
reporter mice (Figure S3F). These results demonstrate that Th17
cells from SFB-positive, but not from SFB-negative, mice prefer-
entially recognize SFB antigens and are, therefore, enriched for
SFB specificities.
Most Lamina Propria Th17 Cells Recognize SFB
Antigens
The in vitro coculture experiments showed that LP Th17 cells
from SFB-positive mice respond to SFB antigens. However,
the strong proliferative response in these experiments can be
due to expansion of a small subset of clones within the starting
Th17 population. To more directly quantify the proportion of LP
Th17 cells that recognize SFB antigens, we decided to query
the TCR specificities of individual cells in the total LP Th17
population. To this goal, we generated a collection of T cell
hybridomas from GFP+ (Th17) and GFP (non-Th17) SI LP CD4
T cells, isolated from SFB-positive mice and examined the
response of individual clones to SFB and control bacteria. As
shown on Figure 3A, 43 out of 94 hybridomas from LP Th17 cells,
Immunity
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cell hybridomas (3 out of 96) responded to SFB (Figure 3A). Most
Th17 cell hybridomas responded strongly to SFB (50%–100% of
the maximum anti-CD3/anti-CD28 stimulation) and did not
respond to E. coli or C. perfringens antigens (Figure 3B; data
not shown). In comparison, the three positive hybridomas from
non-Th17 cells responded weakly (5%–35%), though specif-
ically, to SFB antigens (Figure 3B). Taking into account that
Th17 cells from SFB-negative mice do not respond to SFB anti-
gens and that there is 5- to 7-fold Th17 cell increase upon SFB
colonization, the hybridoma results show the presence of at least
55%–57%SFB-reactive cells in the SFB-induced Th17 cell pop-
ulation. This response was diverse and polyclonal, as demon-
strated by the sequences of SFB-responsive hybridomas (Table
S1). Fourteen out of 15 sequenced SFB-responsive hybridomas
had unique TCRb CDR3 junctions with diverse lengths (Table
S1). SFB-induced Th17 cells in vivo, and Th17 cell hybridomas
used a wide range of Vb gene segments, though we did note a
relative abundance of Vb14 TCRs (Figure S4; Table S1). We
therefore conclude that most SFB-induced Th17 cells recognize
SFB antigens and this SFB-specific Th17 cell response is diverse
and polyclonal.
MHCII Expression on DC Is Necessary and Sufficient for
Induction of Th17 Cells by SFB
MHCII expression in the periphery is required for SFB-mediated
Th17 cell induction. We therefore next investigated the nature of
the participating MHCII-expressing cells that present SFB anti-
gens. Several types of MHCII-expressing cells exist in the LP.
These include professional APCs, DCs, and B cells, as well as
other cell types, such as IECs and ILCs. To investigate the role
of professional APCs, we first examined Th17 cell induction
by SFB in the absence of B cells. Th17 cell induction after SFB
colonization occurred normally in Cm-deficient mice (Kitamura
et al., 1991), which lack mature B cells (Figure S5H), demon-
strating that B cells are not required for SFB-mediated Th17
cell induction.
To investigatewhetherMHCII-dependent antigenpresentation
by intestinal DCs is required,wegeneratedmicewithDC-specific
ablation of MHCII (DCDMHCII mice), by intercrossing H2-Ab1flox
mice (Hashimoto et al., 2002) with CD11c-Cre mice (Caton
et al., 2007) (Figure 4). All major LPCD11c+ subsets were present
in DCDMHCII mice in similar numbers; however, they completely
lacked MHCII expression (Figure 4A; Figure S5A). In contrast,
MHCII expression was present on CD11c-negative cells (Fig-
ure 4A), including immunoglobulin A (IgA+) plasma cells and
B220+ B cells, though it was reduced on the latter (Figure S5B).
In the absence of SFB, DCDMHCII mice had slightly increased
Th17 cell percentage over control littermates (Figures 4B and
4C). SFB colonization induced robust Th17 cell differentiation
in control animals. In contrast, SFB colonization did not lead to
a statistical increase in Th17 cells in DCDMHCII mice, even though
SFB numbers and attachment were similar to the littermate
controls (Figures 4B and 4C; Figures S5F and S5G). Ablation
of MHCII on DCs did not affect the expression of major Th17-
inducing cytokines (e.g., IL-6, IL-23, transforming growth
factor-b [TGF-b], IL-1b) or the induction of a number of other
cytokines and enzymes, such as SAA1, SAA3, and iNOS, by
SFB (Figure 4D; Figure S5C), demonstrating lack of majorchanges in the cytokine milieu. We conclude that MHCII expres-
sion on intestinal DCs is required for induction of Th17 cells by
SFB. Consistent with our previous studies (Ivanov et al., 2009),
SFB colonization did not affect Th1 or Treg cell proportions in
WT or DCDMHCII mice (Figures S5D and S5E). Treg cell propor-
tions were increased in the intestinal LP of DCDMHCII mice,
although, as previously reported (Darrasse-Je`ze et al., 2009),
they were decreased in spleen and MLN, suggesting that MHCII
expression on DCs might have different roles in Treg cell control
in gut versus secondary lymphoid organs (Figure S5E).
To examine whether MHCII expression on DCs is sufficient for
induction of Th17 cells by SFB, we examined Th17 cell induction
in mice in which MHCII expression is restricted to CD11c+ cells
(MHCIICD11c mice) (Lemos et al., 2003). Because MHCIICD11c
mice lack MHCII expression on thymic epithelium and are defi-
cient in CD4 thymic positive selection, we performed adoptive
transfers. As in previous experiments, transfer of WT CD4
T cells led to an SFB-dependent Th17 cell induction in the SI
LP, which was abrogated in the absence of peripheral MHCII
expression in MHCII-deficient recipients (Figures 4E and 4F).
Transfer of WT CD4 T cells into littermate MHCIICD11c mice led
to considerable induction of Th17 cells in the transferred
cells, demonstrating that recovery of MHCII expression only on
CD11c+ cells is sufficient to promote Th17 cell induction (Figures
4E and 4F).
Combined, these results show thatMHCII expression on intes-
tinal DCs is necessary and sufficient for SFB-mediated induction
of Th17 cells.
MHCII Expression on ILCs Controls Intestinal Th17 Cells
Several other nonconventional antigen-presenting cell subsets
express MHCII in the intestine. These include IECs and ILCs
(Hepworth et al., 2013; Hershberg and Mayer, 2000). MHCII
expression on IECs has an unknown function and is controlled
by commensal bacteria (Umesaki et al., 1995). Notably, MHCII
expression on IECs was induced very specifically by SFB only
in the terminal ileum (Figure 5A; data not shown). To investigate
the role of IEC MHCII expression in SFB-mediated Th17 cell
induction, we generated IECDMHCII mice, in which MHCII was
deleted only on IECs by crossing H2-Ab1flox mice with Villin-
Cremice (Madison et al., 2002) (Figures S6A and S6C). Coloniza-
tion of SFB-free IECDMHCII mice with SFB (Figures S6A and S6B)
led to induction of Th17 cells, similar to that in littermate controls
(Figures 5B and 5C), demonstrating that MHCII expression on
IECs is not required for this process.
We also discovered that a subset of intestinal ILCs express
MHCII (Figure 5D), as also reported recently (Hepworth et al.,
2013). A large proportion of LinRORgt+ ILC3 cells express
MHCII (Figure 5D). MHCII expression was most prevalent in
c-kit+NKp46RORgt+ ILCs, and on only a small fraction of
NKp46+ or c-kit ILCs (Figure 5D; Figure S6D). To examine the
role of MHCII expression on ILCs in SFB-mediated Th17 cell
induction, we generated ILC3DMHCII mice, in which MHCII was
deleted only on RORgt+ ILCs by intercrossing MHCII-floxed
mice with RORgt-Cre mice (Eberl and Littman, 2004) (Figure 5D;
Figures S6D and S6E). All three ILC3 subsets were present
in ILC3DMHCII mice (data not shown). MHCII expression was
completely ablated on LinNKp46c-kit+RORgt+ LTi-like cells
and significantly decreased in the small subset of MHCII+ cellsImmunity 40, 594–607, April 17, 2014 ª2014 Elsevier Inc. 599
Figure 4. DC Expression of MHCII Is Necessary and Sufficient for SFB-Mediated Th17 Cell Induction
(A) SI LP lymphocytes from DCDMHCII and control littermates. Left panels, gated on TCRbCD4 cells. Right panels, gated on CD11c+ cells.
(B and C) Th17 cell induction in DCDMHCII mice and control littermates 2 weeks after SFB colonization. Plots gated on TCRb+CD4+ cells. Representative data from
four independent experiments are shown.
(D) Relative cytokine expression (RT-PCR) in terminal ileum of DCDMHCII and control littermates (WT) 2 weeks after colonization with SFB. nd, below threshold of
detection.
(E and F) Th17 cell differentiation of WT CD45.1+ CD4 T cells in the SI LP 2 weeks after transfer into SFB-positive H2-Ab1+/, H2-Ab1 /, and H2-Ab1CD11c
CD45.2+ recipient littermates. Data from two independent experiments are shown. Error bars represent SD of the mean.
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ILC3DMHCII mice did not demonstrate any signs of rectal prolapse
or intestinal inflammation in our colony, and MHCII deletion on
ILC3s did not affect the percentage of SI LP Tregs (Figures
S6F and S6G). Surprisingly, in contrast to SFB-free control litter-
mates, which had low numbers of Th17 cells, ILC3DMHCII animals
contained high percentage and numbers of SI LP Th17 cells even
in the absence of SFB (Figures 5E and 5F). SFB-free ILC3DMHCII
mice contained as many Th17 cells as SFB-colonized WT litter-
mates (Figure 5F). Colonization of WT mice with fecal bacteria
from SFB-negative ILC3DMHCII animals did not induce Th17 cells,
arguing against an outgrowth of other Th17 cell-inducing bacte-
ria (Figure S6H). In contrast to Th17 cells in SFB-positive WT
animals, Th17 cells in SFB-negative ILC3DMHCII mice did not
respond to SFB antigens in vitro (Figure S6I). Colonization with
SFB induced further increase in both percentages and total
numbers of Th17 cells in 9-week-old ILC3DMHCII mice (Figure 5F;600 Immunity 40, 594–607, April 17, 2014 ª2014 Elsevier Inc.Figures S6J and S6K). In agreement with our observation that
SFB induce SFB-specific Th17 cells, SFB colonization induced
Th17 TCR repertoire changes in ILC3DMHCII mice, such as the in-
duction of Vb14+IL-17+ CD4 T cells (Figure 5E; Figure S6L), and a
response to SFB antigens in vitro (Figure S6I). Collectively, these
results demonstrate that Th17 cells are increased in SFB-nega-
tive ILC3DMHCII mice, but SFB are still capable of inducing Th17
cells in these animals.
Th17 Cell Induction by SFB Does Not Require LN or
Organized GALT
Our results show that SFB antigens are presented by iDCs in the
context of MHCII to induce SFB-specific Th17 cells. To examine
the site of Th17 cell priming inWTmice, we analyzed the kinetics
of SFB-mediated CD4 T cell proliferation and Th17 cell differen-
tiation in different tissues following adoptive transfer (Figure 6).
CD4 T cells were purified from spleens and LNs of Il17GFP
Figure 5. RORgt+ ILCs Inhibit Differentiation of SFB-Independent Intestinal Th17 Cells through MHCII
(A) MHCII expression on IECs in Jackson B6 mice before and 2 weeks after SFB colonization. Arrows point to SFB filaments attaching to IECs.
(B and C) Th17 cell induction in IECDMHCII mice and control littermates 2 weeks after SFB colonization. Plots gated on TCRb+CD4+ cells. Data from one of two
independent experiments are shown.
(D) Expression of MHCII on SI LP c-kit+NKp46RORgt+ group 3 ILCs in ILC3DMHCII mice and control littermates.
(E and F) Th17 cell induction in ILC3DMHCII and control littermates 2 weeks after SFB colonization. Plots gated on TCRb+CD4+ cells. Data from two independent
experiments are shown. Error bars represent SD of the mean.
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congenic WT recipients before or after SFB colonization. Prolif-
eration was scored by dye dilution and Th17 cell differentiation
by induction of GFP (IL-17) expression at different time points
after transfer. A small number of proliferating transfer cells
were first detected in the SI LP at day 3 after transfer (Figure 6A).
The number of proliferating cells increased by day 5 and some of
those produced IL-17, again only in the SI LP, but not in spleen or
MLN. By day 7, transferred cells in SFB-colonized animals prolif-
erated robustly and differentiated into Th17 cells in the SI LP.
T cell proliferation and Th17 cell induction was dependent on
the presence of SFB and was very low in SFB animals (Fig-
ure 6A). In contrast, despite being present in larger numbers,
very few transferred cells proliferated in the MLN at day 7 and
none expressed IL-17 (Figure 6A). Albeit lower than the SI LP,
proliferation and Th17 cell induction was also observed in
Peyer’s Patches (PPs) starting at day 6 (Figure S7). Further in-crease in proliferation and Th17 cell differentiation of transferred
cells in the SI LP was observed at 2 weeks after transfer (Fig-
ure 6B; data not shown). However, we did not detect significant
proliferation or IL-17 expression inMLNs, iLNs, or spleen of SFB-
colonized animals at any time-point, suggesting that SFB prim-
ing and induction of Th17 cells occurs in the small intestine itself
(Figure 6B; data not shown).
To investigate directly whether organizedGALT is required, we
examined the induction of Th17 cells by SFB in lymphotoxin-a
(LTa)-deficient mice. Lta/mice possess a defect in generation
of secondary lymphoid organs and lack PPs and isolated
lymphoid follicles (ILFs) in the intestine, as well as peripheral
lymph nodes, including MLNs. Lta/ animals also lack LP B
cells (Newberry et al., 2002). Despite these defects, induction
of Th17 cells by SFB, including induction of Vb14+IL-17+ cells,
was unimpeded in Lta/ mice (Figure 7), demonstrating that
organized GALT is not required for this process and confirmingImmunity 40, 594–607, April 17, 2014 ª2014 Elsevier Inc. 601
Figure 6. Priming and Induction of Th17 Cells by SFB Occur in the Small Intestine
CellTrace Violet labeled CD45.2+ CD4 T cells from Il17GFP mice were transferred into WT CD45.1+ recipients before (No SFB) or after (+SFB) SFB colonization.
(A and B) Proliferation (A and B) and Th17 cell induction (A) at indicated time points. Plots are gated on CD45.2+TCRb+CD4+ transferred cells. Abbreviations are as
follows: SI LP, small intestinal LP; MLN, mesenteric lymph nodes; SPL, spleen. Combined data from three independent experiments. Error bars represent SD of
the mean.
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antigens can occur outside Peyer’s Patches or MLNs and Th17
cell induction does not require priming in peripheral lymph
nodes, suggesting that iDCs acquire SFB antigens and prime
CD4 T cells locally in the LP.
DISCUSSION
Intestinal T cell homeostasis is a major factor in preventing
chronic intestinal inflammation, while maintaining mucosal im-
munity and response to intestinal infections. The mechanisms
by which commensal microbes modulate T cell homeostasis
are, therefore, of considerable interest but have remained poorly
understood due to the complexity and diversity of commensal-
host interactions. SFB are the only currently known individual
commensal capable of specifically inducingTh17cells.However,
the mechanisms of this induction have not been investigated in
detail. SFB can induce changes in the gut cytokine environment602 Immunity 40, 594–607, April 17, 2014 ª2014 Elsevier Inc.byaffecting cytokine expression fromboth iDCsand IECs (Ivanov
et al., 2009; Shima et al., 2008), but whether these cytokines are
required or sufficient to drive Th17 cell induction is not known.
Here,wefind that simplypresenceofSFB-inducedcytokine envi-
ronment is not sufficient to induce Th17 cells in vivo. However,
presentation of SFB-derived antigens by iDCs is crucial and
drives generation of SFB-specific Th17 cells.
Th17 cells were present in the intestines of MHCII-deficient
mice and therefore Th17 cells can be selected on alternative
ligands. However, SFB colonization did not induce Th17 cells
in H2-Ab1/ animals or in transferred WT CD4 T cells in
H2-Ab1/ recipients. Therefore, even though Th17 cells can
be generated in the absence of MHCII, induction of Th17 cells
by SFB requires MHCII expression in the periphery. These
results also suggest that antigen presentation is crucial for
Th17 cell induction by SFB and that SFB-induced Th17 cells
might have skewed TCR specificities. Indeed, we found that
most intestinal Th17 cells recognize SFB antigens in an
Figure 7. SFB Induce Th17 Cells in the Absence of Secondary Lymphoid Organs
SI LP lymphocytes were isolated from Lta/ and control littermates 2 weeks after colonization with SFB.
(A–C) Th17 and Vb14+IL-17+ cells induction in TCRb+CD4+ cells. Representative data from one of two independent experiments are shown.
(D) Foxp3+ Treg cell proportions in TCRb+CD4+ cells. Combined data from two independent experiments are shown. Error bars represent SD of the mean.
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is quite substantial as demonstrated by our hybridoma experi-
ments, in which close to 60% of independent intestinal Th17
cell TCRs responded to SFB, mostly with strong IL-2 production.
At the same time only 3% of non-Th17 hybridomas from the
same animals responded only weakly to SFB, demonstrating
that most, if not all, SFB-specific T cells become Th17 cells. A
strong MHCII-dependent response to bacterial antigens might
be mediated by the expression of a superantigen. However,
SFB-induced Th17 cells had a diverse Vb-chain usage, and there
was a high diversity in Vb usage among SFB-recognizing hybrid-
omas generated from intestinal Th17 cells. Therefore, Th17 cells
are not likely to be induced by an SFB superantigen but more
likely by conventional presentation of SFB antigens in the
context of MHCII. The importance of Th17 cell priming by SFB
antigens was also illustrated by the fact that SFB colonization
did not induce Th17 cell differentiation in two types of non-SFB
Tg T cells even after activation of the Tg T cells by providing
the cognate antigen and even after placing them in an SFB envi-
ronment that induced Th17 cells in WT cells. Therefore, in addi-
tion to providing an important cytokine environment, SFB alsoprovide antigens for Th17 cell differentiation. Our results differ
from a previous study that showedmicrobiota-dependent induc-
tion of LP Th17 cells in the absence of cognate antigen (Lochner
et al., 2011). The presence of SFB was not specifically examined
in this study, and therefore the effects observed might be due to
other microbial entities, which strongly affect the local cytokine
environment and are antigen and/or MHCII independent. Simi-
larly, we show here that Th17 cells can also be present in the
gut even in the absence of antigen presentation in the context
of MHCII. However, our results clearly show that SFB induce
Th17 cells by a unique mechanism that requires antigen presen-
tation by iDCs. Indeed, our results show that SFB-induced cyto-
kine environment is not sufficient to induce Th17 cell differentia-
tion of non-SFB Tg T cells in the absence, or even presence, of
antigen. It is unclear why SFB-specific CD4 T cells differentiate
preferentially into Th17 cells. Our results show that most Th17
cells in SFB-positive mice are SFB-specific and combined with
our hybridoma experiments suggest that most, if not all, SFB-
specific CD4 T cells in the gut are Th17 cells. To preferentially
induce Th17 cells, SFB might provide antigens that induce an
appropriate amount of TCR stimulation or are presented in theImmunity 40, 594–607, April 17, 2014 ª2014 Elsevier Inc. 603
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were unable to skew Th17 cell differentiation of Tg T cells in SFB-
positive mice by providing the antigen orally or intravenously,
which might differ from the context, way, or location these anti-
gens are delivered in vivo by a commensal (Iqbal et al., 2002). In
this respect, all our efforts to colonize SFB-positive mice con-
taining OTII cells with OVA-expressing E. coliwere unsuccessful.
The number and type of SFB antigens contributing to Th17 cell
induction remain to be determined. Despite an increase in
Vb14+IL-17+ cells, we did not find evidence of oligoclonality.
SFB-induced Th17 cells utilized a diverse range of Vb segments,
and SFB-reacting hybridomas showed a diverse and polyclonal
CDR3 repertoire. This suggests that SFB provide multiple anti-
gens for Th17 cell induction, althoughwe cannot exclude a highly
polyclonal response to an individual antigen. At the same time,
SFB seem to secrete only a handful of proteins as the highly
reduced SFB genome lacks any additional protein secretion
systems, as well as sortase-dependent secretory LPXTG-motif
containing proteins (Sczesnak et al., 2011). Combined, these ob-
servations suggest that Th17 cell-inducing SFB antigens might
be acquired by direct interaction and sampling of the bacteria
by host cells. The geography and mechanisms of this sampling,
as well as all of the participating host cell types, will be important
to examine in detail in future studies. The experiments described
here show that SFB antigens are ultimately acquired by iDCs.
Ablation of MHCII expression on CD11c+ cells resulted in abro-
gation of the effect of SFB on promoting Th17 cell expansion.
Of note, Th17 cells were still present in the LP of SFB-
free DCDMHCII mice in similar proportions, or even increased,
compared to WT littermates, but were not further induced by
SFB. Moreover, when MHCII expression was restricted only to
DCs, in MHCIICD11c mice, transferred WT cells differentiated
into Th17 cells in an SFB-dependent matter. Therefore, MHCII
expression on intestinal DCs is both required and sufficient for
the induction of Th17 cells by SFB. The CD11c+ subset that we
term DCs here represents at least three developmentally and
functionally distinct subsets that include CD103+ conventional
DCs and CX3CR1+ monocytes (Bogunovic et al., 2012; Farache
et al., 2013). Both CD103+ and CX3CR1+ cells have been impli-
cated in mucosal Th17 cell differentiation, generally through pro-
duction of Th17 cell-inducing cytokines (Bogunovic et al., 2012;
Farache et al., 2013). In contrast, here we show that one or
several of these subsets must also present SFB antigens in order
for SFB to induce Th17 cells. Further studies will be needed to
dissect the specific role of each of the three CD11c+ subsets in
the process.
How and where SFB antigens are delivered or acquired by the
DCs is also unknown. Most antigen-specific responses in the LP
originate in secondary lymphoid organs, such as PPs andMLNs.
However, induction of commensal-specific IgA might also occur
in the lamina propria itself (Fagarasan et al., 2001; Fritz et al.,
2012). Whether antigen-specific mucosal T cell responses are
exclusively initiated in MLNs and PPs is less clear. An earlier
study found normal numbers of Th17 cells in PP null but MLN-
sufficient mice, suggesting that Th17 cell responses do not
require PPs (Atarashi et al., 2008). To examine the niche for
Th17 cell priming by SFB, we followed proliferation and IL-17 in-
duction of transferred CD4 T cells. SFB-specific T cell prolifera-
tion, followed by IL-17 expression occurred shortly after transfer604 Immunity 40, 594–607, April 17, 2014 ª2014 Elsevier Inc.only in the small intestine, including SI LP and PPs, although pro-
liferation was always higher in the SI LP. Proliferation and IL-17
expression were not observed in peripheral secondary lymphoid
tissues, including MLNs. In addition, SFB-colonization induced
normal numbers of Th17 cells in Lta/ mice, which lack all
peripheral LNs and PPs. Combined, these data suggest that
SFB-mediated T cell priming and Th17 cell differentiation occur
locally in the small intestine. This means that SFB antigens are
acquired by iDCs and presented directly in the intestinal mucosa.
The normal induction of Th17 cells in Lta/ mice demonstrates
that the process can take place in the SI LP in the absence of
PPs. However in WT mice SFB antigens might be delivered in
both PPs and LP, and further studies will be needed to pinpoint
the exact mechanism of this acquisition. SFB are closely associ-
ated with the intestinal epithelium in the terminal ileum. Therefore
direct sampling of SFB might occur, for example, through inter-
digitating DCs or absorption of damaged or apoptotic IECs
(Rescigno et al., 2001; Torchinsky et al., 2009).
In further support that Th17 cell homeostasis is controlled by
signals locally in the LP, we found that lack of MHCII expression
on RORgt+ ILCs leads to an increase in Th17 cell differentiation.
ILC3DMHCII mice had an increase in Th17 cell proportions even in
the absence of SFB. An earlier study found that break in T cell
homeostasis in ILC3DMHCII mice leads to intestinal inflammation
at 12 weeks of age, correlated with increased IL-17 and IL-22
cytokine production (Hepworth et al., 2013). Inflammation and
cytokine production were alleviated after antibiotic treatment,
demonstrating dependence on intestinal bacteria (Hepworth
et al., 2013). In contrast, we did not observe any rectal prolapse
or evidence of intestinal inflammation in ILC3DMHCII mice in our
colony up to 30 weeks of age. Nevertheless, the increase in
Th17 cells was present as early as 6 weeks of age (data not
shown). Therefore, ILCs inhibit Th17 cell differentiation in the
gut in an MHCII-dependent manner. The increase in Th17 cells
most likely leads to intestinal pathology in the presence of proin-
flammatory microbiota (Hepworth et al., 2013); however, our re-
sults suggest that the effect on T cell homeostasis precedes that
of the proinflammatory microbiota. Our results are in agreement
with the conclusion of an earlier report that ILCs inhibit Th17 cell
differentiation (Qiu et al., 2013). In this study, the effect was
attributed to a negative control on SFB colonization. Increase
in SFB numbers in ILC-deficient mice leads to more Th17 cells
and increase in intestinal inflammation (Qiu et al., 2013). In
contrast, the ILC-mediated inhibition of Th17 cell differentiation
that we report here is clearly SFB-independent. Moreover, the
presence of SFB, even in the presence of larger numbers of
Th17 cells did not lead to an increase in intestinal inflammation,
arguing that the increase in intestinal inflammation in models
with decreased ILC function depends on the presence of other
local intestinal pathogens (Hepworth et al., 2013; Qiu et al.,
2013). SFB-negative ILC3DMHCII mice contained as many Th17
cells as SFB-positive WT mice. Nevertheless, SFB were still
able to induce Th17 cells in these animals. Our experiments
demonstrate the existence of SFB-dependent and SFB-inde-
pendent intestinal Th17 cells, controlled by different homeostatic
mechanisms and by different innate immune subsets. How this
occurs requires further study. Our experiments show that Th17
cells present in the absence of SFB in ILC3DMHCII mice and
Th17 cells induced by SFB have different specificities and are
Immunity
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priming context or by different types of antigen-presenting cells.
As we show here, acquisition and presentation of SFB antigens
involves selective sampling by iDCs in the LP and skewed Th17
cell induction. In contrast, loss of epithelial barrier function and
increased bacterial translocation that have been reported in
ILC3DMHCII mice (Hepworth et al., 2013), will likely lead to Th17
cell induction by alternative mechanisms. More studies will be
needed to establish whether SFB-dependent and SFB-indepen-
dent intestinal Th17 cells differ functionally andwhether the SFB-
mediated Th17 cell induction is an evolutionary adaptation for
bacterial colonization or an alternative mechanism of Th17 cell
induction acquired by the host.
Our results shed further light into the complex interactions
involved in controlling intestinal Th17 cell homeostasis. Antigen
presentation by MHCII plays a central role in the induction of
Th17 cells by commensal microbiota. Intestinal DCs acquire an-
tigens from Th17 cell-inducing bacteria to promote antigen-spe-
cific Th17 responses locally in the lamina propria. At the same
time, RORgt+ ILCs control excessive Th17 cell responses by
inhibiting Th17 cell differentiation also in an MHCII-dependent
manner. Further characterization of this process, such as identi-
fication of the participating SFB antigens or the involvement of
specific subsets of DCs or ILCs, will help in better understanding
the molecular and cellular mechanisms involved in the host-
commensal crosstalk regulating T cell homeostasis in the gut.
EXPERIMENTAL PROCEDURES
Mice
MHCII-floxed (H2-Ab1F/F), Cd11c-Cre, Vil-Cre, Cm-deficient, Il17GFP, TRP-
1.RAG1, and Lta/ mice were obtained from Jackson Laboratory. Rorc-Cre
mice (Eberl and Littman, 2004) were a gift fromDan Littman (NYU). MHCII-defi-
cient (H2-Ab1/), OTII.B6, and OTII.RAG1 mice were obtained from Taconic
Farms, the latter through the NIAID Exchange Program (Barnden et al., 1998).
MHCIICD11c mice (also known as CD11c-Abb mice) were previously described
(Lemos et al., 2003). All mice were bred and housed under specific pathogen-
free conditions at Columbia University Medical Center. To control for micro-
biota and caging effects, we performed all experiments with littermate control
and gene-deleted animals housed in the same cage.
SFB Colonization and Th17 Cell Induction
Bacterial genomic DNA isolation from fecal pellets and quantitative PCR for the
SFB 16S rRNA gene were performed as previously described (Ivanov et al.,
2009). SFB colonization was performed by oral gavage with fecal pellets
from SFB-monocolonized mice or with fecal pellets from SFB-negative Jack-
son B6 mice colonized with feces from SFB-monocolonized mice unless
otherwise noted. Control mice were gavaged with fecal pellets from SFB-
negative littermates. SI LP Th17 cell induction was assessed 2–3 weeks after
colonization.
Activation of TCR Tg T Cells
To activate TCR Tg T cells, we fedOTII.B6 andOTII.RAG Tgmice 1%OVA pro-
tein in the drinking water for 12 days. In addition, the mice were orally gavaged
with 50 mg of OVA protein (OVA, grade V; Sigma) on days 1, 3, and 5. TRP-
1.RAG Tg mice were immunized intraperitoneally with 50 mg TRP1 peptide
(CGTCRPGWRGAACNQKILTVR, 92% purity, Biomatik) in DPBS and 10 mg
LPS (Sigma-Aldrich) on days 1 and 7. Control animals were immunized only
with 10 mg LPS in DPBS.
Lamina Propria Cell Isolation and Adoptive Transfers
Lamina propria lymphocytes, intracellular cytokine staining, and Foxp3 stain-
ing were performed as previously described (Ivanov et al., 2008). For adoptive
transfers, 5–10 3 106 MACS-purified CD4 T cells (Miltenyi Biotec; 95%–98%purity) or 5 3 106 FACS sorted TCRb+CD4+CD62LhiCD44lo naive T cells (BD
Influx cell sorter) were transferred intravenously into Ly5.1 WT recipients
before or 10–14 days after SFB colonization. Th17 cell induction in transferred
cells in different tissues was assessed 2 weeks after transfer unless otherwise
noted. In some experiments, cells were labeled with CellTrace Violet prolifer-
ation dye (Life Technologies).
In Vitro Coculture Experiments
LP TCRb+CD4+ T cell subsets were purified by cell sorting and labeled with
CellTrace Violet proliferation dye. 5 3 104 CD4 T cells were cocultured in
96-well U-bottom plates with either 5 3 104 MACS purified splenic CD11c+
cells or 2 3 105 total TCRa-KO splenocytes as APCs in the presence
or absence of autoclaved bacterial lysates. T cell proliferation was assessed
72 hr later by dye dilution. For SFB antigens, SFB filaments were purified
from feces of SFB-monocolonized mice. Briefly, individual fecal pellets from
SFB-monocolonized mice were homogenized in PBS. The supernatant was
cleared from debris by several low-speed centrifugations and bacteria were
pelleted by centrifugation at 4,000 g and washed twice with PBS. After the final
wash, the pellet was resuspended in PBS and layered onto 60%w/v Nycodenz
density gradient. SFB filaments were collected at the interphase and the
procedure repeated. Finally, the SFB filaments were washed twice in PBS.
SFB and other bacterial antigens were prepared by autoclaving bacterial sus-
pensions and used at 1:200 dilution.
Hybridoma Generation and Screening
FACS-purified SI LP TCRb+CD4+GFP+ and TCRb+CD4+GFP T cells were
stimulated in vitro for 3 days in tissue culture plates coated with 5 mg/ml
each of anti-CD3 and anti-CD28 mAbs, fused with BW5147 thymoma (White
et al., 1989) and plated in limited dilutions in selective media. Individual clones
were picked 10 days later and expanded in 24-well plates. The response of
cloned hybridomas toward autoclaved bacterial lysates was measured with
the HT-2 assay (Pacholczyk et al., 2007). In brief, 105 hybridoma cells were
stimulated with plate-bound aCD3/aCD28 (positive control) or incubated
with 105 bone-marrow-derived dendritic cells (or splenocytes from TCRa-KO
mice) alone (no antigen control), or with SFB, E. coli, orClostridium perfringens
lysates. After 24 hr, the amount of secreted IL-2 was measured with the detec-
tor HT-2 cell line. The proliferation of HT-2 cells in response to IL-2 was
measured with the MTT (Sigma) assay (Pacholczyk et al., 2007), and the
response for each hybridoma was plotted as a percentage from the IL-2
response in the aCD3/aCD28-stimulated positive control.
Statistics
Significance was scored by using an unpaired two-tailed t test unless other-
wise noted. p values were represented on figures as follows: ns, p R 0.05,
*p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001, *****p < 0.0005, ******p <
0.0001. Error bars on all figures represent SD of the mean.
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